Page last updated: 2024-08-25

voriconazole and Infant, Premature, Diseases

voriconazole has been researched along with Infant, Premature, Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Cornely, O; Janssen, S; Mehler, K; Oberthuer, A; Seifert, H; Zweigner, J1
Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A1
Eifinger, F; Frankenbusch, K; Kribs, A; Rengelshauseu, J; Roth, B1
Benjamin, DK; Cotten, CM; Perfect, JR; Schell, WA; Smith, PB; Steinbach, WJ; Walsh, TJ1
Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ1

Reviews

1 review(s) available for voriconazole and Infant, Premature, Diseases

ArticleYear
Rhodotorula fungemia: two cases and a brief review.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2011

Other Studies

4 other study(ies) available for voriconazole and Infant, Premature, Diseases

ArticleYear
Molds and More: Rare Fungal Infections in Preterm Infants <24 Weeks of Gestation.
    The Pediatric infectious disease journal, 2022, 04-01, Volume: 41, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Female; Fungi; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Mycoses; Pregnancy; Voriconazole

2022
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
    Journal of perinatology : official journal of the California Perinatal Association, 2006, Volume: 26, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Drug Resistance, Fungal; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pyrimidines; Triazoles; Voriconazole

2006
Caspofungin for the treatment of azole resistant candidemia in a premature infant.
    Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:2

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Hypercalcemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007